Enhancing Adverse Drug Reaction Reporting in Pediatrics and Its Impact on Public Health: A Systematic Review and Meta-Analyses
DOI:
https://doi.org/10.5281/zenodo.10206795Keywords:
Adverse Drug Reaction, Hospitalized children, Meta-analysis, PediatricsAbstract
Adverse drug reactions (ADRs) pose a significant public health concern, especially in pediatrics. ADRs are defined as any undesirable or unintended response to a drug, ranging from mild and self-limited to severe and life-threatening. It is estimated that ADRs affect up to 25% of hospitalized children, making them a leading cause of morbidity and mortality in this population. This study aimed to comprehensively review available evidence regarding the effectiveness of different interventions in enhancing ADR reporting in pediatric populations. In October 2023, we conducted a search on the electronic database Medline PubMed without imposing limitations on the publication date or geographic area, excluding all secondary and tertiary literature. Data were extracted from identified studies using a structured data extraction form in Microsoft Office Excel® 2016. The systematic search yielded a total of 108 records. After removing seven duplicate records, 101 distinct records underwent title and abstract screening. Six were excluded due to language restrictions or irrelevance to the research topic. Subsequent full-text assessment for eligibility resulted in the exclusion of an additional 79 records, primarily due to the absence of intervention in the study design. Ultimately, 16 studies were deemed suitable for quantitative synthesis. This systematic review and meta-analysis revealed that interventions aimed at improving adverse drug reaction detection and reporting increased identification compared to standard practice in children. However, concerns about significant issues related to bias and heterogeneity threaten the reliability of our results.
References
Aagaard, L., Christensen, A., & Hansen, E. H. (2010). Information about adverse drug reactions reported in children: a qualitative review of empirical studies. British Journal of Clinical Pharmacology, 70(4), 481–491.
Andrade, P. H. S., Lobo, I. M. F., & da Silva, W. B. (2017). Risk factors for adverse drug reactions in pediatric inpatients: A cohort study. PloS One, 12(8), e0182327.
Baek, H. J., Cho, Y. S., Kim, K. S., Lee, J., Kang, H. R., & Suh, D. I. (2016). Multidisciplinary approach to improve spontaneous ADR reporting in the pediatric outpatient setting: a single-institute experience in Korea. Springerplus, 5, 1–8.
Balsamo, C., Del Bono, C., Pagano, G., Valastro, V., Ghizzi, C., & Lombardi, F. (2022). Pediatric Adverse Drug Reactions: An Observational Cohort Study After Health Care Workers’ Training. The Journal of Pediatric Pharmacology and Therapeutics, 27(4), 324–329.
Cammack, B., Oschman, A., & Lewis, T. (2019). Improving recognition and reporting of adverse drug reactions in the NICU: a quality improvement project. Pediatric Quality & Safety, 4(5).
Carleton, B. C., Poole, R. L., Smith, M. A., Leeder, J. S., Ghannadan, R., Ross, C. J. D., … Hayden, M. R. (2009). Adverse drug reaction active surveillance: developing a national network in Canada’s children’s hospitals. Pharmacoepidemiology and Drug Safety, 18(8), 713–721.
Clarkson, A., Ingleby, E., Choonara, I., Bryan, P., & Arlett, P. (2001). A novel scheme for the reporting of adverse drug reactions. Archives of Disease in Childhood, 84(4), 337–339. https://doi.org/10.1136/adc.84.4.337
Co, J. P. T., Johnson, S. A., Poon, E. G., Fiskio, J., Rao, S. R., Cleave, J. Van, … Ferris, T. G. (2010). Electronic health record decision support and quality of care for children with ADHD. Pediatrics, 126(2), 239–246.
Dittrich, A. T. M., Draaisma, J. M. T., van Puijenbroek, E. P., & Loo, D. M. W. M. te. (2020). Analysis of reporting adverse drug reactions in paediatric patients in a university hospital in the Netherlands. Pediatric Drugs, 22, 425–432.
Dreyer, N. A., Velentgas, P., Westrich, K., & Dubois, R. (2014). The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and caution. Journal of Managed Care Pharmacy, 20(3), 301–308.
Fang, H., Lin, X., Zhang, J., Hong, Z., Sugiyama, K., Nozaki, T., … Asakawa, T. (2017). Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China. BMC Pharmacology and Toxicology, 18, 1–9.
Figueiras, A., Herdeiro, M. T., Polónia, J., & Gestal-Otero, J. J. (2006). An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. Jama, 296(9), 1086–1093.
Goldman, J. L., Sullins, A., Sandritter, T., Leeder, J. S., & Lowry, J. (2013). Pediatric pharmacovigilance: enhancing adverse drug reaction reporting in a tertiary care children’s hospital. Therapeutic Innovation & Regulatory Science, 47(5), 566–571.
Gonzalez-Gonzalez, C., Lopez-Gonzalez, E., Herdeiro, M. T., & Figueiras, A. (2013). Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Safety, 36, 317–328.
Hazell, L., & Shakir, S. A. W. (2006). Under-reporting of adverse drug reactions. Drug Safety, 29(5), 385–396.
Hui, C., Vaillancourt, R., Bair, L., Wong, E., & King, J. W. (2016). Accuracy of adverse drug reaction documentation upon implementation of an ambulatory electronic health record system. Drugs-Real World Outcomes, 3, 231–238.
Impicciatore, P., Choonara, I., Clarkson, A., Provasi, D., Pandolfini, C., & Bonati, M. (2001). Incidence of adverse drug reactions in paediatric in/out‐patients: a systematic review and meta‐analysis of prospective studies. British Journal of Clinical Pharmacology, 52(1), 77–83.
jin Kim, H., & Hwang, S. Y. (2022). Effect of Website-based Learning on Improved Monitoring of Adverse Drug Reactions by Clinical Nurses. Asian Nursing Research, 16(1), 45–51.
Kronenfeld, N., Gamsu, S., Keidar, R., Livneh, A., Berkovitch, M., Goldman, M., … Abu-Kishk, I. (2019). The role of an interventional program for improving pharmacovigilance at a pediatric facility. Frontiers in Pharmacology, 10, 1004.
Leitzen, S., Dubrall, D., Toni, I., Stingl, J., Christ, P., Köberle, U., … Sachs, B. (2023). Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports. Pediatric Drugs, 25(2), 203–215.
Li, R., Zaidi, S. T. R., Chen, T., & Castelino, R. (2020). Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: a systematic review. Pharmacoepidemiology and Drug Safety, 29(1), 1–8.
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., … Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of Internal Medicine, 151(4), W-65.
Lombardi, N., Crescioli, G., Bettiol, A., Tuccori, M., Capuano, A., Bonaiuti, R., … Vannacci, A. (2020). Italian emergency department visits and hospitalizations for outpatients’ adverse drug events: 12-year active pharmacovigilance surveillance (The MEREAFaPS Study). Frontiers in Pharmacology, 11, 412.
Lopez-Gonzalez, E., Herdeiro, M. T., & Figueiras, A. (2009). Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Safety, 32, 19–31.
Lopez-Gonzalez, E., Herdeiro, M. T., Piñeiro-Lamas, M., Figueiras, A., & Group, G. (2015). Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial. Drug Safety, 38, 189–196.
McGettigan, P., Golden, J., Conroy, R. M., Arthur, N., & Feely, J. (1997). Reporting of adverse drug reactions by hospital doctors and the response to intervention. British Journal of Clinical Pharmacology, 44(1), 98–100.
Mejía, G., Saiz-Rodríguez, M., Gómez de Olea, B., Ochoa, D., & Abad-Santos, F. (2020). Urgent hospital admissions caused by adverse drug reactions and medication errors—a population-based study in Spain. Frontiers in Pharmacology, 11, 734.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Group*, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine, 151(4), 264–269.
Musdar, T. A. (2019). Faktor yang mempengaruhi praktik pelaporan Adverse Drug Reactions (ADRs) oleh tenaga di beberapa rumah sakit wilayah kota Surabaya. Universitas Airlangga.
Nam, Y.-H., Nam, H.-J., Song, J.-E., & Lee, S.-K. (2015). A comparative analysis of adverse drug reactions: pre-and post regional pharmacovigilance center in a single tertiary hospital. World Allergy Organization Journal, 8, A60–A60.
Neubert, A., Dormann, H., Weiss, J., Criegee-Rieck, M., Ackermann, A., Levy, M., … Rascher, W. (2006). Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? European Journal of Clinical Pharmacology, 62, 959–965.
Patel, P. B., Patel, T. K., Anturlikar, S., Khatun, S., Bhabhor, P., & Saurabh, M. K. (2017). Adverse drug reactions reporting by undergraduate medical students in a tertiary care teaching hospital of India: Content and quality analysis in comparison to physician reporting. Perspectives in Clinical Research, 8(3), 137.
Paudyal, V., Al-Hamid, A., Bowen, M., Hadi, M. A., Hasan, S. S., Jalal, Z., & Stewart, D. (2020). Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis. Expert Opinion on Drug Safety, 19(9), 1173–1191.
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., … Breckenridge, A. M. (2004). Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj, 329(7456), 15–19.
Potlog Shchory, M., Goldstein, L. H., Arcavi, L., Shihmanter, R., Berkovitch, M., & Levy, A. (2020). Increasing adverse drug reaction reporting—How can we do better? PLoS One, 15(8), e0235591.
Pulford, A., & Malcolm, W. (2010). Knowledge and attitudes to reporting adverse drug reactions. British Journal of Nursing, 19(14), 899–904.
Reumerman, M., Tichelaar, J., Piersma, B., Richir, M. C., & Van Agtmael, M. A. (2018). Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. European Journal of Clinical Pharmacology, 74, 1235–1248.
Ríos, O. M., Gutiérrez, L. J., Talavera, J. O., Téllez-Rojo, M. M., López, V. O., Espinosa, J. G., & Hernández, O. M. (2016). A comprehensive intervention for adverse drug reactions identification and reporting in a pediatric emergency department. International Journal of Clinical Pharmacy, 38, 80–87.
Soyer, J., Necsoiu, D., Desjardins, I., Lebel, D., & Bussières, J.-F. (2019). Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding. Archives de Pédiatrie, 26(7), 400–406.
Thiesen, S., Conroy, E. J., Bellis, J. R., Bracken, L. E., Mannix, H. L., Bird, K. A., … Peak, M. (2013). Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children–a prospective observational cohort study of 6,601 admissions. BMC Medicine, 11(1), 1–10.
Tillman, E. M., Suppes, S. L., Feldman, K., & Goldman, J. L. (2021). Enhancing pediatric adverse drug reaction documentation in the electronic medical record. The Journal of Clinical Pharmacology, 61(2), 181–186.
Tripathy, R., Das, S., Das, P., Mohakud, N. K., & Das, M. (2021). Adverse drug reactions in the pediatric population: Findings from the adverse drug reaction monitoring center of a teaching hospital in Odisha (2015-2020). Cureus, 13(11).
Walsh, D., Lavan, A., Cushen, A.-M., & Williams, D. (2015). Adverse drug reactions as a cause of admission to a Dublin-based university teaching hospital. Irish Journal of Medical Science (1971-), 184, 441–447.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Wildlife and Biodiversity
This work is licensed under a Creative Commons Attribution 4.0 International License.
JWB applies the 